Elevated N-Terminal Pro-B-Type Natriuretic Peptide (Nt-Probnp) Levels in Critically Ill Patients with Normal Transthoracic Echocardiogram and Normal Renal Function Tests
DOI:
https://doi.org/10.51253/pafmj.v75i6.9691Keywords:
Amino-terminal probrain natriuretic peptide; Brain natriuretic peptide; B-type natriuretic peptides; natriuretic peptide.Abstract
Objective: To determine frequency of critically ill patients who have elevated N-terminal pro-B-type natriuretic peptide (NT-proBNP) levels with normal transthoracic echocardiogram and normal renal function tests.
Study Design: Descriptive cross-sectional study.
Place and Duration of Study: Medical Intensive Care Unit (ICU) of Pak Emirates Military Hospital, Rawalpindi Pakistan, from Jan to Jul 2022
Methodology: All patients fulfilling inclusion criteria and admitted in ICU of PEMH over the duration of study were enrolled in the study through non-probability consecutive sampling. Data for 50 patients was collected and their NT-proBNP levels in pg/mL were measured at admission and compared with reference limit based on age, for excluding congestive heart failure (CHF) after which frequency and percentage of patients with elevated NT-proBNP levels was calculated.
Results: Majority of critically ill patients with normal transthoracic echocardiogram and normal renal function tests had elevated NT-proBNP levels. Out of 50 patients included in this study, 37(74 %) had elevated NT-proBNP levels.
Conclusion: At the time of admission in ICU, critically ill patients with normal transthoracic echocardiogram and normal renal function tests had markedly elevated NT-proBNP levels. Thus, NT-proBNP levels alone cannot be reliably used in critically ill patients to rule out heart failure.
Downloads
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Kamran Mahmood Dar, Zulqarnain Saleem, Kamil Hussain, Abbas Malik, Asad Zaman Khan

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.





